Article Information
PubMed
Published By
History
- Received March 22, 1999
- Revision received May 24, 1999
- Accepted May 24, 1999
- First published August 15, 1999.
- Version of record published August 15, 1999.
Copyright & Usage
Copyright © 1999 Society for Neuroscience
Author Information
- Claudia Verderio1,
- Silvia Coco1,
- Alberto Bacci1,
- Ornella Rossetto2,
- Pietro De Camilli3,
- Cesare Montecucco2, and
- Michela Matteoli1
- 1Consiglio Nazionale delle Ricerche Cellular and Molecular Pharmacology and B. Ceccarelli Centers, Department of Medical Pharmacology, 20129 Milano, Italy;
- 2Dipartimento di Scienze Biomediche, Consiglio Nazionale delle Ricerche-Centro Biomembrane, University of Padova, 35122 Padova, Italy, and
- 3Howard Hughes Medical Institute and Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut 06510
Author contributions
Disclosures
- Received March 22, 1999.
- Revision received May 24, 1999.
- Accepted May 24, 1999.
This work has been supported by Telethon Grants 1042 (to M.M.) and 1068 (to C.M.), by Human Frontier Science Program (to M.M. and P.D.C.), by the European Community Grants Biomed 2 BMH4 CT97 2410 (to C.M.) and BIO4–98-0408 (to M.M.), and by National Institutes of Health Grant NS36251 (to P.D.C.). We acknowledge Dr. R. Jahn (Gottingen, Germany) for gift of antibodies against synaptophysin, synaptobrevin/VAMP2, rab3a, and synaptotagmin.
Correspondence should be addressed to Michela Matteoli, Consiglio Nazionale delle Ricerche Cellular and Molecular Pharmacology, and B. Ceccarelli Centers, Department of Medical Pharmacology, University of Milano, via Vanvitelli 32, 20129 Milano, Italy.
Online Impact